Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Globus Medical, Inc. Class A Common Stock (NY:GMED)

60.57 +0.55 (+0.92%)
Official Closing Price Updated: 7:00 PM EDT, Aug 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023
 
Via Benzinga
NuVasive Specialized Orthopedics Launches Precice Bone Transport in International Markets
From Globus Medical
Via GlobeNewswire
The Latest Analyst Ratings for Globus Medical
 
Via Benzinga
Where Globus Medical Stands With Analysts
 
Via Benzinga
Globus Medical (GMED) Q2 2023 Earnings Call Transcript
GMED earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Expert Ratings for Globus Medical
 
Via Benzinga
Analyst Expectations for Globus Medical's Future
 
Via Benzinga
Globus Medical Completes Merger with NuVasive
From Globus Medical
Via GlobeNewswire
Globus Medical Reports Second Quarter 2023 Results
From Globus Medical
Via GlobeNewswire
Globus Medical Announces Launch of the MARVEL™ Growing Rod System, the company’s first product designed specifically for early onset scoliosis
MARVEL™ is Globus Medical’s second major release this year in the pediatric scoliosis space 
From Globus Medical
Via GlobeNewswire
Globus Medical (GMED) Q1 2023 Earnings Call Transcript
GMED earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Globus Medical: Q1 Earnings Insights
 
Via Benzinga
What 8 Analyst Ratings Have To Say About Globus Medical
 
Via Benzinga
Globus Medical Earnings Preview
 
Via Benzinga
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
Globus Medical Announces FDA Approval for its Non-Fusion Scoliosis Correction System, the Latest Advancement for Young Patients with Idiopathic Scoliosis
REFLECT™ is approved through the FDA’s Humanitarian Device Exemption pathway 
From Globus Medical
Via GlobeNewswire
Globus Medical Reports First Quarter 2023 Results
From Globus Medical
Via GlobeNewswire
6 Analysts Have This to Say About Globus Medical
 
Via Benzinga
Globus Medical Shareholders Approve Share Issuance for Merger with NuVasive
From Globus Medical
Via GlobeNewswire
Globus Medical Schedules First Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
7 Stocks to Buy with Bulletproof Balance Sheets
If you believe a recession is coming – and that’s what the data suggest – you should consider these stocks with strong balance sheets. 
Via InvestorPlace
Minimally Invasive Surgery — This Company's Successful Trial Could Help Eliminate The Need For An Incision In Patients With Back Pain
As medical technology progresses, the world’s approach to surgical operations is also advancing and changing significantly. As part of this, minimally invasive surgery (MIS), in recent years, has taken... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
 
Via Benzinga
Inflation, TikTok, and Other Hot Stories Investors Are Talking About
We've also got the latest in automotive, homebuilding, and the war on cash. 
Via The Motley Fool
Top 5 Health Care Stocks That May Rocket Higher In Q1 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Globus Medical (GMED) Q4 2022 Earnings Call Transcript
GMED earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Globus Medical Reports Fourth Quarter and Full Year 2022 Results
From Globus Medical
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For February 13, 2023
 
Via Benzinga
Top 5 Health Care Stocks That Could Blast Off This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2023
 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.